Ballicules.com

Micafungin

MYCAMINE

What it isEchinocandin inhibiting fungal beta-1,3-glucan synthesis; invasive candidiasis.

Why this oneIts labeled Candida-prophylaxis role in stem-cell transplantation distinguishes it from other echinocandins.

What limits itNo CNS or urinary penetration, so it fails in meningitis and cystitis. Not active against Aspergillus alone.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Candidemia, acute disseminated candidiasis, Candida peritonitis/abscessesAdult100 mg QD100 mg QD100 mg QD
Candidemia/disseminated candidiasis/peritonitis/abscessesPeds ≥4 mo2 mg/kg QD2 mg/kg QD100 mg/day
Candidemia/disseminated (without meningoencephalitis/ocular dissem.)Peds <4 mo4 mg/kg QD4 mg/kg QD
Esophageal candidiasisAdult150 mg QD150 mg QD150 mg QD
Esophageal candidiasisPeds ≥4 mo3 mg/kg QD (≤30 kg); 2.5 mg/kg QD (>30 kg)150 mg/day
Prophylaxis of Candida in HSCT recipientsAdult50 mg QD50 mg QD50 mg QD
Prophylaxis of Candida in HSCT recipientsPeds ≥4 mo1 mg/kg QD50 mg/day

Renal No adjustment needed

Hepatic No adjustment needed

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy May cause fetal harm based on animal data (visceral abnormalities, abortion in rabbits); insufficient human data

Lactation No human data; present in rat milk; weigh benefits against maternal need

NO BOXED WARNINGS

Principal riskNo CNS or urinary penetration

Cost, est. cash$20–$1,500/dose or month

Generic entry2019

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityHepatotoxicity and clinically important CYP/QT interactions; organ toxicity varies markedly by agent.

Mechanism of action: Micafungin ballicule

Micafungin ballicule: receptor binding, kinetics and half-life diagram

Open Micafungin in the interactive console ↗